Clinical Trials Logo

Clinical Trial Details — Status: Not yet recruiting

Administrative data

NCT number NCT01180088
Other study ID # AA001
Secondary ID
Status Not yet recruiting
Phase N/A
First received August 9, 2010
Last updated August 10, 2010
Start date August 2010
Est. completion date August 2011

Study information

Verified date August 2010
Source Azienda Ospedaliera Ordine Mauriziano di Torino
Contact n/a
Is FDA regulated No
Health authority Italy: Ethics Committee
Study type Interventional

Clinical Trial Summary

The aim of this study was to evaluated the advantages of routine application of the anterior approach in patients scheduled to right hepatectomy or extended right hepatectomy, without infiltration of segment 1, inferior vena cava or main bile duct.


Description:

Mobilization of the liver during right hepatectomy with classic approach is performed before parenchymal transection. In this phase severe bleeding may occur due to laceration of the inferior vena cava (IVC) wall, rupture or ligation falling off the hepatic short vein (HSV) or bleeding from the right liver attachments. Besides, the twisting of the portal pedicle during mobilization can render the left hepatic lobe ischemic for transient interruption of the hepatopetal flow. These events are more frequent in case of large hepatic lesions (mainly HCC) that involves surrounding structures (such as diaphragm). Two of the most important factors that affect the postoperative course of patients undergoing liver resections are indeed intraoperative bleeding and postoperative liver dysfunction. For these reasons Lai et al proposed anterior approach as alternative to classic right hepatectomy. In this case liver mobilization is performed only at the end of parenchymal transection, when all vascular connections are already interrupted. Liu et al published the results of a retrospective study in which 54 patients with, right sided HCC greater than 5 cm underwent right hepatectomy using the anterior approach technique. The anterior approach group had significantly less intraoperative blood loss, less need of blood transfusion and a lower hospital mortality rate. The same group reported results of a prospective randomized controlled study analyzing 120 patients with large (>5 cm) right liver HCC. The overall operative blood loss, morbidity, and duration of hospital stay were comparable in both groups. However, a higher number of patients in classic approach group experienced mayor operative blood loss (> 2000 cc) and required blood transfusions (8.3% vs. 28.3%).


Recruitment information / eligibility

Status Not yet recruiting
Enrollment 60
Est. completion date August 2011
Est. primary completion date September 2010
Accepts healthy volunteers No
Gender Both
Age group 18 Years to 80 Years
Eligibility Inclusion Criteria:

- patients between 18 and 80 years

- patients scheduled to right hepatectomy or extended right hepatectomy

- the future remnant liver (FRL) = 25% in patients with a normal liver or = 30% in those with chronic liver disease

- indocyanine green retention rate (ICG) at 15 minutes = 10% in cirrhotic patients

Exclusion Criteria:

- resection of S1

- resection of bile duct

- infiltration of inferior vena cava

- America Society of Anesthesiologists (ASA) grade IV

- Emergency surgery

Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment


Related Conditions & MeSH terms


Intervention

Procedure:
RIGHT HEPATECTOMY WITH CLASSIC APPROACH
The right portal branch and the right branch of the hepatic artery were identified, dissected and divided. Extraparenchymal ligation of pedicles for Sg4 was performed in case of extended right hepatectomy. The falciform and the right triangular ligaments were sectioned and the right liver up to the retrohepatic vena cava was totally mobilized by section and sutures of the accessory right hepatic veins. The right hepatic vein was controlled in an extrahepatic plane and encircled with a tape. At the end of parenchymal transection right hepatic vein was sectioned with endovascular stapler. The right bile duct and middle hepatic vein (in case of extended right hepatectomy) were divided intraparenchymally

Locations

Country Name City State
Italy Ospedale Mauriziano di Torino Turin

Sponsors (1)

Lead Sponsor Collaborator
Azienda Ospedaliera Ordine Mauriziano di Torino

Country where clinical trial is conducted

Italy, 

References & Publications (3)

Lai EC, Fan ST, Lo CM, Chu KM, Liu CL. Anterior approach for difficult major right hepatectomy. World J Surg. 1996 Mar-Apr;20(3):314-7; discussion 318. — View Citation

Liu CL, Fan ST, Cheung ST, Lo CM, Ng IO, Wong J. Anterior approach versus conventional approach right hepatic resection for large hepatocellular carcinoma: a prospective randomized controlled study. Ann Surg. 2006 Aug;244(2):194-203. — View Citation

Liu CL, Fan ST, Lo CM, Tung-Ping Poon R, Wong J. Anterior approach for major right hepatic resection for large hepatocellular carcinoma. Ann Surg. 2000 Jul;232(1):25-31. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary OVERALL BLOOD LOSS UP TO 7 DAYS No
Secondary BLOOD TRANSFUSION RATE WITHIN 24 HOURS No
See also
  Status Clinical Trial Phase
Completed NCT02557724 - Mobilization of Mesenchymal Stem Cells During Liver Transplantation
Terminated NCT04702230 - Value of Functional Magnetic Resonance Imaging of Hepatocellular Carcinoma After Transarterial Chemoembolization or Transarterial Radioembolization
Active, not recruiting NCT01217034 - Transcatheter Arterial Chemoembolization Therapy In Combination With Sorafenib Phase 2
Recruiting NCT05169177 - Radio-opaque Contrast Agents for Liver Cancer Targeting With KIM During Radiation Therapy
Withdrawn NCT02599909 - Gut Microbiota in People With Hepatocellular Carcinoma (HCC)
Terminated NCT03998033 - Study of ET140202 T Cells in Adults With Advanced Hepatocellular Carcinoma Phase 1
Recruiting NCT04010071 - Axitinib Plus Toripalimab as Second-line Treatment in Hepatobiliary Malignant Tumors Phase 2
Recruiting NCT04864054 - T-Cell Therapy (ECT204) in Adults With Advanced HCC Phase 2
Terminated NCT04187937 - Feasibility of Ultrasound-based Navigation for Non-anatomical Liver Resections N/A
Completed NCT02471313 - Integrated Imaging Strategy to Phenotype Progression of Liver Tumors During and After Chemoembolization Phase 2
Completed NCT00001576 - A Phase I Study of Isolated Hepatic Perfusion With Escalating Dose Melphalan Followed by Postoperative Hepatic Arterial Floxuridine and Leucovorin for Metastatic Unresectable Colorectal Cancers of the Liver Phase 1
Recruiting NCT01542281 - Pre-habilitation to Improve Outcomes in Patients Undergoing Liver Resection for Cancer N/A
Recruiting NCT03803436 - Improving Outcome of Selected Patients With Non-resectable Hepatic Metastases From Colo-rectal Cancer With Liver Transplantation Phase 2
Completed NCT05495529 - Biliary or Digestive Protection by Room Air Interposition for Thermal Ablation of Central Hepatic Tumors
Recruiting NCT02632864 - Feasibility of High Dose PROton Therapy On Unresectable Primary Carcinoma Of Liver: Prospective Phase II Trial Phase 2
Completed NCT02571946 - Proton Beam Therapy in Hepatocellular Carcinoma With Portal Vein Tumor Thrombosis N/A
Withdrawn NCT00510627 - Study Comparing Radio Frequency Ablation Plus Chemotherapy and Chemotherapy Alone in Patients With Secondary Liver Metastases Phase 4
Completed NCT05848947 - SIR-Spheres Study to Calculate the Radiation-Absorbed Dose of 99mTc-MAA Phase 4
Not yet recruiting NCT05723705 - Impact of a European Training Program for Robotic Liver Surgery (LIVEROBOT)
Terminated NCT04502082 - Study of ET140203 T Cells in Adults With Advanced Hepatocellular Carcinoma (ARYA-1) Phase 1/Phase 2